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"The poorest of all laboratory work is that done
in the private physician's office." That allegation was
made by the Director of the New York City Department of Health Bureau of Laboratories in a statement to a Senate Committee of the Judiciary Committee on Antitrust and Monopoly on February 7,
1967 ( 1). Statements such as this typify the public
relations problem facing directors of office laboratories today. The problem is twofold: First, how can
the quality of the office laboratory be assured and
documented? Second, how can this information be
disseminated to legislators and the general public?
The first is an easily solved technical problem toward
which this paper is directed. The second and probably the most difficult is a media problem beyond
the scope of a technical journal.
Laboratory quality assurance and documentation
are best considered as a subset of the more general
field of quality control, an industrial discipline with
its roots in the industrial revolution. Industrial quality control is the technique, for instance, whereby
the automotive industry may precisely design obsolescence into an automobile without impinging on
the warranty period in order to maximize profits.
Quality control in the drug industry assures not only
that the amount of drug in a pill falls within acceptable tolerances but that the pill itself is not malformed. A malformed pill results in very bad public
relations for the drug company, even if its function is
not impaired. The pigeon, an animal with a very
fine eye for detail, has been used successfully for
assembly line quality assurance in removing faulty
pills prior to packaging (2). Laboratory medicine
also produces a product which can be subjected to
quality control, the laboratory result.

* Presented by Dr. Riddick at the 44th Annual McGuire
Lecture Series, March 22, 1973, at the Medical College of
Virginia, Richmond.
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Error Frequency Distributions. Any discussion
of laboratory quality control should begin with a
brief account of practical statistics, since statistics is
the science whereby a decision can be made as to
whether a laboratory result is acceptable or unacceptable. An introduction to these statistics should
begin with the error frequency distribution.
If a unit of outdated blood bank blood is mixed
well and dispensed into 100 test tubes, this set of
tubes is called a "pool." The plasma glucose content
of any one of these tubes is the same as that of any
other, since all tubes came from the same bag of
blood. If one attempts to assay each of those 100
tubes of blood for glucose, however, the assay results will not be identical for all tubes. Some will be
above an average value and some below, as shown
in the histogram in figure 1. A few results will deviate
markedly from the average value but most will
cluster around the average. The smooth curve (sometimes called Gaussian or bell-shaped) drawn through
the steps of the histogram is called a frequency distribution plot, and it can be used to make a decision
as to when a laboratory result deviates too far from
the average value of the pool. If one calculates a socalled standard deviation (SD), one can define location of the cutoff point between acceptable and
unacceptable results. The use of the standard deviation has two advantages over a single intuitive guess
about where the line between good and bad data
lies. First, use of the standard deviation (actually ±
2SD) as a decision point guarantees that 95 % of the
results will be in the acceptable range on the average.
Second, standard deviation is used by most practitioners of laboratory medicine and is understood by
them, thereby providing a common ground for discussion. It might be mentioned that the frequency
distribution plot shown in figure 1 is a real life situation. That is, it is technically impossible to get
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Fig. I-Frequency histogram of Gaussian distribution with
overlying frequency distribution plot. Note that the majority
of values cluster around the peak of the curve.

identical results for the plasma glucose in each of
those 100 tubes. One can use more costly and difficult methods and the range on the horizontal axis
will narrow, but the results cannot be made identical.
This means that there is no "true" value for the
glucose in the plasma. Analytical balances used for
weighing the glucose also have error frequency
distributions.
Frequency Distributions of Normal Patient
Laboratory Determinations. Figure 2 shows the results obtained for blood urea nitrogen determined on
each of 495 "healthy" patients plotted in the same
fashion as the pool results in figure 1. As might be
expected, most of the results cluster around an average value with a few markedly deviant values to the
left and right of center. Notice that the frequency
distribution plot is skewed with more deviant values
to the right (occult disease?) than to the left. This
is because there is no such thing as a negative blood
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urea nitrogen, so the curve is steeper on the left than
on the right.
Now, suppose one took a large number of
patients with renal disease, drew their blood, performed a blood urea nitrogen on them, and superimposed their frequency distribution plot on an
idealized plot of the frequency distribution of urea
nitrogen of "normal" patients (fig. 3). How might
one define the upper limits of "normal" using this
data? One might draw a vertical line at the lowest
point between the normal peak and the sick peak
and call this the upper limit of normal. It is obvious,
however, that the two curves overlap and in the areas
of overlap, some normal patients will be called sick
when they are not, and some sick patients will be
called normal when they are not. Anyone experienced with the SMA 12-60 has seen elevated uric
acids in perfectly normal people who never develop
gout. To further complicate things, a large laboratory error component will tend to broaden this range
of ambiguity to an even greater extent.
Effect of Methodology on Normal Ranges. Figure 4 shows frequency distribution plots of two different assay methods for blood glucose-the glucose
oxidase and the ferricyanide methods. The glucose
oxidase method is a so-called "true glucose" method
and produces comparatively low results, partly because it is subject to inhibition by some patients'
blood. The classical ferricyanide glucose method, on
the other hand, produces comparatively high results
because it measures not only true glucose but also
other reducing substances such as fructose and
glyceraldehyde. From the point of view of the patient
and his physician, the important thing is the normal
range. The glucose oxidase blood glucose normal
range is 10-20 mg percent lower than that of the
ferricyanide method. If one used both methods
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Fig. 2-Urea nitrogen frequency distribution plot. Notice
that there are far more deviant results on the high side of
the curve than on the low side; that is, the curve is skewed.
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F ig. 3- Superimposed frequency distribution plots of normal and abnormal urea nitrogen determinations. Note the
area of ambiguity or overlap between the sick and the well
person.
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Fig. 4-Frequency distribution plots for two different blood
glucose methods. Note that the normal range is different for
each.

simultaneously, one would widen the normal range
as shown in the composite curve in figure 4 and a
substantial increase in false negative blood glucose
results would occur. This could easily happen if two
different kits using different methodology were used
interchangeably. The result would be a component
of laboratory error which would widen considerably
the range of ambiguity of the blood glucose data.
Effect of Methodology on "Biologic Variation."
Figure 5 is a time-course plot of the blood sodium
level of the author drawn over a period of a month.
The upper curve (JHR) represents the human blood;
the two lower curves (Control 1 and Control 2) are
two commercial pools assayed simultaneously with
the human blood. Had there been no laboratory
error, the lower plots (Control 1 and Control 2)
would be perfectly straight lines parallel to the horizontal axis. Note that the two curves are sawtooth
instead, describing day-to-day laboratory error. Because of within-day random error, or perhaps because of pipetting error they are not exactly parallel
to one another. The most striking feature of
figure 5 is that the human serum drawn on the same
day shows the same pattern of variation. The implication is that a substantial component of so-called
"biologic variation" for serum sodium actually is
laboratory error. Carefully controlled studies such as
this, in fact, indicate that the flame photometer is
incapable of measuring the subtle changes of biologic
variation and that, in fact, all variations measured
in normal human blood sodium are actually laboratory error not biologic variation. Many other blood
components, potassium, for example, show similar
effects of day-to-day laboratory error. If one could
reduce the day-to-day error component in measuring
blood sodium, one might be able to pick up more

subtle changes, the normal range would undoubtedly
shrink and fewer false negative and false positive
results would occur. The cost of increased accuracy
and precision, however, is prohibitive at present.
Setting of Control Limits and the Effect on
Patient Care. Figure 6 is a graphic example of the
effect of control limits set too wide in the laboratory.
Bilirubin is traditionally a poor test from an accuracy standpoint because of the difficulty of maintaining adequate standards which will not deteriorate. The error shown in figure 6, however, is caused
by an improperly calibrated reference serum used
to calibrate the SMA 12-60 bilirubin. On day 20,
the laboratory used the last of a particular manufacturer's reference serum and began to use a new lot
from a different manufacturer. The effect was an
abrupt increase in every normal patient's bilirubin
of 0.4 mg percent and an increase in the bilirubin
of the patients in the moderately elevated range of
0 .7 mg percent. Obviously the normal range was
widened by this change. Tighter control limits would
have detected this change sooner. Furthermore, an
alert visual scan by a physician of the patient results
for the day would have proven to be an extremely
useful form of quality control. It was concluded that
one could not rely upon the manufacturer's brochure
provided with the lots of reference serum.
Some Simple Techniques for Quality Control.
One of the oldest forms of laboratory quality control
is the "repeat." If one doubts the validity of the
first result, send another one and compare the two.

150
-JHR DATA
-CONTROL I

140
~

~
....

130

~

120

ti

110

IOO

-coNTROL2
2/2

214

2/5

2/9

2117

2/24

3/5

DATES DONE

Fig. 5-Time course plot of the blood sodiu m level of the
author drawn over a period of 30 days. The upper curve
represents the human blood (JHR). The lower curves (Control 1 and Control 2) represent pooled control sera. The
parallel variation indicates that the greater part of the "diurnel variation" of the human sodium actually represents
analytical variation.
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Fig. 6-The effect of a change of control pool manufacturer
on day 20. Notice the striking change in levels of bilirubin
for the control pool.

This is of no use, however, if a very poor laboratory
is very good at reproducing its bad results on repeats.
The split sample is a slightly more sophisticated
form of the repeat. In this case, the original sample

is mixed well and divided into two parts. A phony
name is attached to one specimen and the second
member is submitted to the laboratory sometime
later. This technique is designed to foil the laboratorian who claims that "biologic variation" caused
the difference in the two results. A rule of thumb for
the split sample is that if the results of the two split
samples vary by more than 10% the results are
suspect. This figure varies from test to test. The
split sample is also useful in those tests for which
reference standards are not yet available such as
urinalysis, bacteriology and even some coagulation
studies.
Another more complex method of quality control is the mixed specimen. This works best with
blood chemistries. If you mix known amounts of
each of two patient specimens, the results of all
components ( excluding enzymes) will be proportional
to the original concentrations and volumes mixed.
The calculation for the predicted results is fairly
straightforward.
Most people rapidly tire of the exercise of preparing their own quality control samples and purchase these from some national program such as
the Proficiency Evaluation Program (PEP) for the
Physician's Office Laboratory.
Proficiency Evaluation Program for the Physician's Office Laboratory. Beginning in April, 1973,
the College of American Pathologists and the American Society of Internal Medicine are jointly sponsoring a quality control program designed specifically
for the physician's office laboratory. The data obtained are treated in an entirely confidential manner
and meet the demands of public health agencies,
legislators, professional associations and patients for
a third party evaluation of the office laboratory.
Quarterly kits are mailed out to subscribers containing seven vials of test unknowns and a blood smear.
These vials contain material for evaluating hemoglobin, red cell counts, hematocrit, glucose, bilirubin,
cholesterol, urea, uric acid, urine specific gravity,
urine protein, urine reducing substance, urine bilirubin, urine hemoglobin, urine pH, prothrombin
time, white cell count, urine bacteriology and peripheral smear. One hundred tests per year are performed on a quarterly basis and mailed into the
testing agency for evaluation. Four weeks after receipt, results from all subscribing laboratories are
pooled, processed by computer, and a computer
print out is mailed to all subscribers giving name of
constituent, method used, subscriber's result pass or
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fail code, average of all laboratories for comparison,
a good performance range and an acceptable performance range. In addition, a quarterly bulletin is
sent to all subscribers, describing findings and including a personalized certificate for wall-mounting.
The advantages of such a system are apparent.
First, the director gets a confidential warning that
his laboratory is having difficulty, thus giving him
the opportunity to correct the difficulty. Comparison
of results with peers is always informative as to the
wide interlaboratory differences. The effort expended
is minimal and does not disrupt the normal func-
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tion of the laboratory and the cost is far less than
manual preparation of samples and data collection.
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